Pacer Advisors, Inc. Neurocrine Biosciences Inc Transaction History
Pacer Advisors, Inc.
- $38.6 Billion
- Q1 2024
A detailed history of Pacer Advisors, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 18,108 shares of NBIX stock, worth $2.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,108
Previous 14,608
23.96%
Holding current value
$2.5 Million
Previous $1.92 Million
29.78%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding NBIX
# of Institutions
628Shares Held
94.4MCall Options Held
505KPut Options Held
343K-
Black Rock Inc. New York, NY13.8MShares$1.9 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.37 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$552 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$317 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$311 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...